Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03424161 · ClinicalTrials.gov registry record · NA
Multi-Center, Clinical Evaluation of the Cutera Secret RF Device
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03424161: Completed NA study, sponsored by Cutera.
NCT03424161 is a NA study that has completed, run by Cutera. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03424161, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate the efficacy and safety of the Cutera Secret RF device.
Primary Outcome
Efficacy of treatment(s) with Cutera Secret RF measuring the global skin improvement at the 4 week follow-up visit, and at the 12 week follow-up visit as assessed by the study investigator using GAIS: Global Aesthetic Improvement Scale (+4=Very Significant Improvement, +3=Significant Improvement, +2=Moderate Improvement, +1=Mild Improvement, or 0=No Change Higher scores indicate better outcomes
Interventions
- DEVICE Secret RF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2018-10-08 |
| Phase | NA |
What the finished NCT03424161 record still lists
NCT03424161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Secret RF is the first listed.
NCT03424161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03424161 about?
NCT03424161 is a clinical study titled "Multi-Center, Clinical Evaluation of the Cutera Secret RF Device". The objectives of this study are to evaluate the efficacy and safety of the Cutera Secret RF device.
What is the current status of trial NCT03424161?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-01-10. Estimated completion is 2018-10-08.
What interventions are being tested in trial NCT03424161?
The interventions under investigation include: Secret RF (DEVICE).
Who is sponsoring clinical trial NCT03424161?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03424161's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI